Innovid Corp. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 1 months to Dec 31, 2020
Cash flows from operating activities:
Net loss
Payment of formation costs through issuance of Class B ordinary shares
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and long-lived assets impairment
Goodwill impairment
Stock-based compensation
Loss on sale of property and equipment
Change in fair value of warrants
Founders notes forgiven
Transaction costs allocated to warrants
Non-cash interest expense
Loss on foreign exchange, net
Changes in operating assets and liabilities
Trade receivables, net
Prepaid expenses and other assets
Operating lease right of use assets
Trade payables
Employees and payroll accruals
Operating lease liabilities
Accrued expenses and other liabilities
Net cash provided by / (used in) operating activities
Cash and cash equivalents
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired
(Increase)/ decrease in deposits
Internal use software capitalization
Purchase of property and equipment
Founders’ note receivable
Proceeds from sale of property and equipment
Investment in short-term bank deposits
Withdrawal of short-term bank deposits
Other deposits
Net cash used in) investing activities
Cash flows from financing activities:
Proceeds from reverse recapitalization, net*
Proceeds from reverse recapitalization, net
Capital contributions
Proceeds from issuance of preferred stock, net
Proceeds from loans
Loan repayment
Repayment of acquisition liability
Payment of SPAC merger transaction costs
Proceeds from exercise of options
Net cash provided by financing activities
Effect of exchange rates on cash, cash equivalent and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of the year
Cash, cash equivalents and restricted cash, end of the year
Supplemental disclosures:
Income taxes paid, net of tax refunds
Interest paid
Non-cash transactions
Conversion of redeemable convertible preferred stock into common stock
Conversion of Legacy Innovid Warrants
Accrued acquisition liability
Accretion of preferred stocks to redemption value
Accrued transaction cost, not yet paid
Business combination consideration paid in stock
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents
Deferred offering costs included in accrued offering costs
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares
Deferred offering costs paid through promissory note - related party
Long-term restricted deposits
Restricted cash in prepaid expenses and other current assets

Comments